Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
Recruiting · NCT04459065 · Registry updated 2024-01-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2024-01-09 | NCT04459065 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Saskatchewan | 35 |
| Western Economic Diversification Canada | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| St. Paul's Hospital | Saskatoon | Canada | 3 |